4:18 PM
Oct 11, 2017
 |  BC Extra  |  Financial News

Medicxi backs University of Toronto spinout Janpix

The University of Toronto Mississauga and investment firm Medicxi launched cancer play Janpix Inc. (Cambridge, Mass.) with a $19 million series A round. CEO Roman Fleck told BioCentury the company has raised a total of $20 million, including a seed round led by Medicxi...

Read the full 206 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >